New York A 4312: Authorizes and directs the commissioner of health to designate HTLV-1 and HTLV-2 communicable diseases; and relates to the HTLV-1 and HTLV-2 viruses

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A04312 Summary:

BILL NOA04312 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORTague

&nbsp

COSPNSRDeStefano, Miller, Durso

&nbsp

MLTSPNSR

&nbsp

Add Art 21 Title 9 §§2185 - 2187, Pub Health L

&nbsp

Authorizes and directs the commissioner of health to designate HTLV-1 and HTLV-2 communicable diseases; requires reporting of HTLV-1 and HTLV-2 cases to the department of health; creates educational materials about the virus.

Go to top A04312 Actions:

BILL NOA04312 

&nbsp

02/04/2025referred to health

01/07/2026referred to health

Go to topA04312 Committee&nbspVotes:

Go to topA04312 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA04312 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 4312

 2025-2026 Regular Sessions

 IN ASSEMBLY

 February 4, 2025
 ___________

 Introduced by M. of A. TAGUE, DeSTEFANO, MILLER, DURSO -- read once and
 referred to the Committee on Health

 AN ACT to authorize and direct the commissioner of health to designate
 HTLV-1 and HTLV-2 communicable diseases; and to amend the public
 health law, in relation to the HTLV-1 and HTLV-2 viruses

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The commissioner of health is hereby authorized and
 2 directed to include HTLV-1 and HTLV-2 in the list of communicable
 3 diseases in the New York state sanitary code.
 4 § 2. Article 21 of the public health law is amended by adding a new
 5 title 9 to read as follows:
 6 TITLE IX
 7 HTLV-1 AND HTLV-2
 8 Section 2185. HTLV-1 and HTLV-2; duty to report.
 9 2186. HTLV-1 and HTLV-2; educational materials.
 10 2187. Rules and regulations.
 11 § 2185. HTLV-1 and HTLV-2; duty to report. 1. Every physician or other
 12 person authorized by law to order diagnostic tests or make a medical
 13 diagnosis, or any laboratory performing such tests shall immediately
 14 upon (a) determination that a person is infected with HTLV-1 or HTLV-2,
 15 and (b) periodic monitoring of HTLV-1 and HTLV-2 infections by any labo-
 16 ratory tests report such case or data to the commissioner within twen-
 17 ty-four hours from the time the case is first seen. If a coroner,
 18 pathologist, medical examiner, or other person qualified to conduct an
 19 examination of a deceased person discovers that at the time of death the
 20 individual was afflicted with HTLV-1 or HTLV-2, they shall report the
 21 case within twenty-four hours to the commissioner as if the diagnosis
 22 had been established prior to death.
 23 2. Reports required under this section shall contain such information
 24 concerning the case as shall be required by the commissioner. These

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD06410-01-5

 A. 4312 2

 1 reports shall contain, but need not be limited to, all medical informa-
 2 tion required to establish accurate numbers for statewide prevalence,
 3 rates of annual incidence, and morbidity and mortality rates.
 4 3. All reports or information secured by the department under the
 5 provisions of this title shall be confidential except: (a) in so far as
 6 is necessary to carry out the provisions of this title; (b) when used in
 7 the aggregate, without patient specific identifying information, in
 8 programs approved by the commissioner for the improvement of the quality
 9 of medical care provided to persons with HTLV-1 or HTLV-2; (c) when used
 10 within the state or local health department by public health disease
 11 programs to assess co-morbidity or completeness of reporting and to
 12 direct program needs, in which case patient specific identifying infor-
 13 mation shall not be disclosed outside the state or local health depart-
 14 ment; or (d) when used for purposes of patient linkage and retention in
 15 care, patient specific identified information may be shared between
 16 local and state health departments and health care providers currently
 17 treating the patient as approved by the commissioner.
 18 § 2186. HTLV-1 and HTLV-2; educational materials. 1. The commissioner
 19 shall develop, produce and make available to physicians, other health
 20 care providers, and other persons at high risk for HTLV-1 and HTLV-2
 21 e